NCT06359834View on ClinicalTrials.gov

Comparison of Remimazolam and Propofol Effect on Oxygen Reserve During Endoscopic Retrograde Cholangiopancreatography

NACompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

April 11, 2024

Primary Completion Date

August 29, 2024

Study Completion Date

August 29, 2024

Conditions
Hepatobiiliary Diseases Requiring Endoscopic Retrograde Cholangiopancreatography
Interventions
DRUG

Remimazolam besylate

Patients in this group receives 0.1mg/kg of remimazolam to induce sedation prior to endoscope insertion. Remimazolam 2mg is added in case of inadequate sedation.

DRUG

Propofol

Patients in this group receives 1mg/kg of propofol to induce sedation prior to endoscope insertion. Propofol 20mg is added in case of inadequate sedation.

Trial Locations (1)

120-752

Division of Gastroenterology, Department of Internal Medicine, Yonsei Institute of Gastroenterology, Yonsei University College of Medicine, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT06359834 - Comparison of Remimazolam and Propofol Effect on Oxygen Reserve During Endoscopic Retrograde Cholangiopancreatography | Biotech Hunter | Biotech Hunter